BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31689805)

  • 1. Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer.
    Park HM; Park SJ; Han SS; Hong SK; Hong EK; Kim SW
    Medicine (Baltimore); 2019 Nov; 98(44):e17711. PubMed ID: 31689805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
    Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy.
    Sakai A; Tsujimae M; Masuda A; Iemoto T; Ashina S; Yamakawa K; Tanaka T; Tanaka S; Yamada Y; Nakano R; Sato Y; Kurosawa M; Ikegawa T; Fujigaki S; Kobayashi T; Shiomi H; Arisaka Y; Itoh T; Kodama Y
    World J Gastroenterol; 2019 Mar; 25(11):1387-1397. PubMed ID: 30918431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.
    Winter JM; Cameron JL; Olino K; Herman JM; de Jong MC; Hruban RH; Wolfgang CL; Eckhauser F; Edil BH; Choti MA; Schulick RD; Pawlik TM
    J Gastrointest Surg; 2010 Feb; 14(2):379-87. PubMed ID: 19911239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy.
    Yoon YS; Kim SW; Park SJ; Lee HS; Jang JY; Choi MG; Kim WH; Lee KU; Park YH
    Ann Surg; 2005 Jul; 242(1):92-100. PubMed ID: 15973106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
    Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
    J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
    Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
    J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.
    Vilhordo DW; Gregório C; Valentini DF; Edelweiss MIA; Uchoa DM; Osvaldt AB
    J Gastrointest Cancer; 2021 Sep; 52(3):872-881. PubMed ID: 32808236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival.
    Allema JH; Reinders ME; van Gulik TM; van Leeuwen DJ; Verbeek PC; de Wit LT; Gouma DJ
    Surgery; 1995 Mar; 117(3):247-53. PubMed ID: 7878528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of surgical treatment for early ampullary cancers and implications for local ampullectomy.
    Song J; Liu H; Li Z; Yang C; Sun Y; Wang C
    BMC Surg; 2015 Mar; 15():32. PubMed ID: 25888004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ampullary cancer: an overview.
    Ahn DH; Bekaii-Saab T
    Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
    Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
    World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater.
    Miura JT; Jayakrishnan TT; Amini A; Johnston FM; Tsai S; Erickson B; Quebbeman EJ; Christians KK; Evans DB; Gamblin TC; Turaga KK
    J Gastrointest Surg; 2014 Nov; 18(11):2003-8. PubMed ID: 25159502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
    Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
    JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.